Followers | 2 |
Posts | 447 |
Boards Moderated | 0 |
Alias Born | 10/18/2018 |
Friday, August 16, 2019 3:50:04 PM
Recent PSTV News
- Plus Therapeutics to Present at the Gordon Research Conference Radionuclide Theranostics for the Management of Cancer • GlobeNewswire Inc. • 07/02/2024 11:30:00 AM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 06/07/2024 09:02:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:02:15 PM
- Plus Therapeutics Expands Management Team and Reports $3.3M Advance Payment from CPRIT • GlobeNewswire Inc. • 06/07/2024 11:30:00 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 06/05/2024 11:26:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:16:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 11:00:11 AM
- Plus Therapeutics Announces New Employment Inducement Grants • GlobeNewswire Inc. • 05/17/2024 09:00:00 PM
- Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 05/15/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:01:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:00:50 PM
- Plus Therapeutics to Announce First Quarter Financial Results and Host Conference Call on May 15, 2024 • GlobeNewswire Inc. • 05/13/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 11:30:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 11:30:17 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 11:30:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 11:30:11 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 11:30:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 11:30:06 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:20:34 PM
- Plus Therapeutics Provides Highlights Regarding Leptomeningeal Metastases Acquisition and Topline Clinical Trial Data on the FORESEE Trial • GlobeNewswire Inc. • 05/09/2024 03:29:23 PM
- Plus Therapeutics to Host Investor Call to Discuss Leptomeningeal Cancer Related Acquisition and Topline Clinical Trial Data from the FORESEE Trial • GlobeNewswire Inc. • 05/08/2024 09:35:00 PM
- Plus Therapeutics Announces Private Placement Financing of up to $18 Million • GlobeNewswire Inc. • 05/06/2024 11:30:00 AM
- Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense • GlobeNewswire Inc. • 04/22/2024 11:00:00 AM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 03/08/2024 09:30:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 09:04:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM